Free Trial
LON:UPR

Uniphar (UPR) Share Price, News & Analysis

Uniphar logo
GBX 300 -1.00 (-0.33%)
As of 05/29/2025 11:51 AM Eastern

About Uniphar Stock (LON:UPR)

Key Stats

Today's Range
300
312
50-Day Range
211.10
306
52-Week Range
163
312
Volume
12,407 shs
Average Volume
32,330 shs
Market Capitalization
£933.85 million
P/E Ratio
20.86
Dividend Yield
0.67%
Price Target
GBX 310
Consensus Rating
Buy

Company Overview

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Uniphar Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

UPR MarketRank™: 

Uniphar scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Uniphar has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Uniphar has only been the subject of 1 research reports in the past 90 days.

  • Read more about Uniphar's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Uniphar is 20.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.32.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Uniphar is 20.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.99.

  • Price to Book Value per Share Ratio

    Uniphar has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for UPR.
  • Dividend Yield

    Uniphar has a dividend yield of 0.77%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Uniphar does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Uniphar is 13.91%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Uniphar's dividend.
  • Short Interest

    There is no current short interest data available for UPR.
  • News Sentiment

    Uniphar has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Uniphar this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    1 people have added Uniphar to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Uniphar insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.07% of the stock of Uniphar is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    45.25% of the stock of Uniphar is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Uniphar's insider trading history.
Receive UPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter.

UPR Stock News Headlines

Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
Uniphar PLC (UPR) Gets a Buy from RBC Capital
Uniphar And Two Other Promising Penny Stocks To Watch
Uniphar plc (UPR.IR)
See More Headlines

UPR Stock Analysis - Frequently Asked Questions

Uniphar's stock was trading at GBX 170.80 on January 1st, 2025. Since then, UPR stock has increased by 75.6% and is now trading at GBX 300.
View the best growth stocks for 2025 here
.

Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Uniphar investors own include IXICO (IXI) and ANGLE (AGL).

Company Calendar

Record date for 5/16 Dividend
4/24/2025
Ex-Dividend for 5/16 Dividend
4/24/2025
Dividend Payable
5/16/2025
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
LON:UPR
CIK
N/A
Fax
N/A
Employees
3,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 310
High Stock Price Target
GBX 310
Low Stock Price Target
GBX 310
Potential Upside/Downside
+3.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
20.86
Forward P/E Ratio
15.94
P/E Growth
N/A
Net Income
£51.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.03 billion
Cash Flow
GBX 30.11 per share
Price / Cash Flow
9.97
Book Value
GBX 127.58 per share
Price / Book
2.35

Miscellaneous

Free Float
N/A
Market Cap
£933.85 million
Optionable
Not Optionable
Beta
0.75
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:UPR) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners